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Summary
Protein ubiquitination is critical for numerous cellular
functions, including DNA damage response pathways
[1, 2]. Histones are the most abundant monoubiquitin
conjugates in mammalian cells; however, the regula-
tion and the function of monoubiquitinated H2A
(uH2A) and H2B (uH2B) remain poorly understood. In
particular, little is known aboutmammalian deubiquiti-
nating enzymes (DUBs) that catalyze the removal of
ubiquitin from uH2A/uH2B. Here we identify the ubiq-
uitin-specific protease 3 USP3 as a deubiquitinating
enzyme for uH2A and uH2B. USP3 dynamically asso-
ciates with chromatin and deubiquitinates H2A/H2B
in vivo. The ZnF-UBP domain of USP3 mediates uH2A-
USP3 interaction. Functional ablation of USP3 byRNAi
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erlands.leads to delay of S phase progression and to
accumulation of DNA breaks, with ensuing activation
of DNA damage checkpoint pathways. In addition, we
show that in response to ionizing radiation, (1) uH2A
redistributes and colocalizes in g-H2AX DNA repair
foci and (2) USP3 is required for full deubiquitination
of ubiquitin-conjugates/uH2A and g-H2AX dephos-
phorylation. Our studies identify USP3 as a novel reg-
ulator of H2A and H2B ubiquitination, highlight its role
in preventing replication stress, and suggest its in-
volvement in the response to DNA double-strand
breaks. Together, our results implicateUSP3asanovel
chromatin modifier in the maintenance of genome
integrity.
Results and Discussion
USP3 Is a Chromatin-Associated DUB
To identify nuclear proteins involved in histone (de)ubi-
quitination, we employed affinity chromatography on
Ub-agarose of chromatin-enriched nuclear fractions.
MALDI-TOF mass spectrometric analysis identified the
E1 enzyme and the DUBs Ub-specific protease 5 (USP5/
isopeptidaseT)and Ub-specificprotease3 (USP3)aspro-
teins specifically interacting with Ub-agarose (Figure 1A).
USP3 has been characterized as a functional DUB in
vitro, and it is the human DUB most homologous to S.
cerevisiae Ubp8, which regulates H2B deubiquitination
[3–5]. Analysis of USP3 subcellular localization con-
firmed that USP3 is a nuclear protein and that it is pres-
ent in the chromatin fraction (Figure S1 in the Supple-
mental Data available online).
USP3 Regulates the Cellular Levels of Ubiquitinated
H2A and H2B
To address a potential function of USP3 in chromatin
regulation, we ectopically expressed USP3 in HeLa cells
and analyzed the ubiquitination state of histones (Fig-
ures 1B–1D). Approximately 5%–15% of histone H2A
and less than 1% of H2B are monoubiquitinated, making
them the two major monoubiquitinated chromosomal
proteins [5]. uH2A was detected by immunoblotting
with anti-Ub, anti-H2A antibodies (Ab), or a monoclonal
Ab specific for uH2A [6], and direct anti-H2B immuno-
blot visualized uH2B (Figures 1C and 1D; Figure S2A).
Both uH2A and uH2B amounts were significantly re-
duced upon USP3 overexpression (Figures 1C and
1D). In contrast, USP5 did not affect the levels of uH2A
(Figure S2B). USP3 did not alter the total pool of ubiqui-
tinated proteins (not shown).
Next, we knocked down USP3 expression in HeLa
cells (USP3-KD) by small interfering RNA (siRNA). Effi-
cient reduction of USP3 protein was accompanied by a
significant increase in the levels of uH2A and, to a lesser
extent, of uH2B (Figure 1E). Altogether, these data
strongly suggest that USP3 is required for H2A and
H2B deubiquitination in vivo.
Histone Deubiquitination by USP3
1973Figure 1. USP3 Is a Regulator of H2A and H2B Ubiquitination In Vivo
(A) Silver stain of nuclear proteins retained on Ub-agarose (Ub-bound) or control (ctrl) beads. Arrows: proteins identified by mass spectrometry;
E1 (P22314), USP3 (Q9Y6I4), USP5 (P45974).
(B–D) Overexpression of USP3 decreases uH2A and uH2B. Whole-cell extracts (WCE) (B) and histone fractions (C and D) of HeLa cells trans-
fected with GFP- or Myc-USP3 were IB as indicated. Asterisk indicates IB H2B shorter exposure.
(E) Increased uH2A and uH2B levels in USP3-depleted cells. HeLa cells were transfected with USP3 targeting oligos (USP3 KD1, KD2; 100 nM,
two rounds of transfection, cells were harvested at 72 hr) or control siRNA (Ctrl). WCE (anti-USP3 and anti-Actin) and histone fractions were IB as
shown. In this and subsequent figures, molecular mass markers are indicated in kDa.USP3 Binds to uH2A and Dynamically Interacts
with Chromatin In Vivo
USP3 harbors two conserved protein domains [3]: a cat-
alytic domain of the Ub-specific protease (USP) class
and a zinc finger (ZnF-UBP) Ub-binding domain [1].
USP3 mutants were generated and monitored for their
deubiquitination activity and histone binding (Figures
2A–2C). To generate an inactive USP3 mutant, we
substituted a serine for the catalytic cysteine of USP3
(Myc-USP3C168S) [7]. To test the potential role of the
ZnF-UBP in ubiquitin/ubiquitinated histone interaction,
we mutated the Zn-binding, conserved histine to alanine
(Myc-USP3H56A) (Figure S3). Only wild-type USP3 signif-
icantly reduced the total pool of uH2A, showing that
both protease activity and an intact zinc finger are re-
quired for H2A deubiquitination (Figure 2B).
To address histone binding, we expressed pIG-
USP3wt, pIG-USP3C168S, or pIG-USP3H56A proteins and
performed coimmunoprecipitation. uH2A could be effi-
ciently coimmunoprecipitated with IG-USP3C168S but
less efficiently with WT USP3 (Figure 2C), possibly
because of rapid release of WT USP3 after catalysis.
Similarly, strong interaction between uH2A and purified
IG-USP3C168S was detected in in vitro pull-down assays,
indicating that USP3 can directly contact its substrate
(Figure S4). In the IG-USP3C168S immunoprecipitates,we also detected native nonubiquitinated core histones
(Figure 2C). However, whereas in bulk chromatin about
5%–15% of total H2A is ubiquitinated [5], in IG-
USP3C168S immunoprecipitates, a 1:1 uH2A/H2A ratio
wasdetected, indicating enrichment foruH2A (Figure 2C,
IB anti-H2A). Increase of uH2B was less apparent. These
results suggest that USP3 is directed to chromatin by a
preferential interaction with uH2A. Consistently, the mu-
tation in the ZnF UBP significantly reduced USP3-uH2A
interaction both in vivo and in vitro (Figure 2C; Figure S4),
indicating that this is the principal domain mediating the
interaction with ubiquitin [1]. Immunoblot with anti-Ub
Ab revealed that uH2A is the most abundant ubiquiti-
nated protein coimmunoprecipitating with USP3C168S,
suggesting that uH2A represents a major USP3 sub-
strate (Figure 2C).
Through an immunofluorescence approach, we could
confirm that the interaction of GFP-USP3C168S with its
chromatin substrate is more stable than that of GFP-
USP3wt (Figure 2D). GFP-USP3wt and GFP-USP3 mu-
tants were all nuclear. However, in Triton X-100-treated
HeLa cells, only GFP-USP3C168S maintained its nuclear
localization. One reasonable explanation for this is
that, whereas the active WT protein transiently interacts
with its substrate, the catalytic mutant functions as a
‘‘substrate trap.’’
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(A) Schematic representation of wild-type (WT) and mutant USP3 proteins. ZnF, zinc finger ubiquitin binding domain (ZnF UBP); USP, ubiquitin-
specific protease domain. All constructs were Myc- (B), GFP- (D–F), or IG- (C) tagged.
(B) 293T cells were transfected with the indicated Myc-USP3 constructs or control GFP and collected after 48 hr. IB was performed on WCE
(USP3, vinculin) or histone fractions, with the indicated Ab.
(C) 293T cells were transfected with expression plasmids as indicated. Cell lysates were immunoprecipitated and IB as shown. (u2H2A), protein
band with a molecular weight consistent with form of H2A harboring two ubiquitin moieties. Asterisks: nonspecific bands.
(D) GFP-USP3wt, GFP-USP3C168S, GFP-USP3H56A, and GFP localization was visualized by fluorescence analysis. Before fixation, cells were
treated with 0.5% Triton X-100 (plus Triton) or mock treated (no Triton). Scale bar represents 20 mm.
(E) FRAP analysis of GFP-USP3wt (blue, n = 20 nuclei), USP3C168S (red; n = 20 nuclei), USP3H56A (light blue; n = 20 nuclei), and GFP (green; n = 20
nuclei) in HeLa cells. The obtained fluorescence recovery curves were normalized to the prebleach fluorescence set at 1.
(F) Kinetic parameters of GFP-USP3wt, USP3C168S, USP3H56A, and GFP as determined by kinetic modeling.Next, we determined the nuclear mobility of GFP-
USP3wt and mutants by FRAP (fluorescent recovery
after photobleaching) [8]. A striking difference in fluores-
cence recovery between GFP-USP3wt and GFP-
USP3C168S was observed (Figures 2E and 2F). Analysis
of the fluorescence recovery plots by fitting to curves
generated by computer simulation of FRAP [9] revealed
that the C168S has a severe impact on both the immo-
bile fraction as on the duration of immobilization. GFP-
USP3C168S displayed a significantly larger immobile
fraction (30%) compared to the WT protein (5%), and
mutant molecules were permanently immobilized (resi-
dence time, defined as 1/Koff = infinite; Koff = 0), whereas
residence time for GFP-USP3wt was in the subsecond
range (0.25 s). GFP-USP3H56A immobile fraction was
comparable to GFP-USP3wt, whereas its residence
time was greatly prolonged (>64 s). This may be ex-
plained by a reduced catalytic rate of this mutant, as
supported by its inability to deubiquitinate H2A
(Figure 2B) and consistent with studies on USP5 [10].
The dynamic properties of the WT protein suggest that
a significant fraction of USP3 molecules is recruitedwith a very high frequency and transiently at target sites,
probably through an interaction with its substrate(s)
uH2A/uH2B, to execute deubiquitination.
USP3 Depletion Delays S Phase Progression
and Mitotic Entry
To examine the role of USP3, we knocked down its ex-
pression in U2OS cells by siRNA. USP3-KD resulted in
slower growth (Figure S5). To investigate whether
USP3 depletion altered cell-cycle progression, we syn-
chronized siRNA-transfected cells at the beginning of S
phase by thymidine and followed the cell cycle upon re-
lease. USP3-KD cells showed a profound delay in
S phase progression with most of the cells in middle
S phase at 9 hr after release (Figure 3A). Also, compared
to control cells, only a minor fraction of USP3-KD cells in-
corporated BrdU at all time points (Figure 3B). Therefore,
both FACS analysis and 50-BrdU labeling demonstrated
that USP3 depletion causes a replication defect. Finally,
we found that very few mitotic cells accumulated over
time in USP3-KD, compared to control cells (Figure S6).
Accumulation of DNA damage during defective DNA
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1975Figure 3. USP3 Knockdown Delays S Phase Progression, Induces DNA Damage, and Activates DNA Damage Checkpoints
(A and B) U2OS cells, transfected with control (Ctrl) or USP3-silencing oligos, were blocked with thymidine for 24 hr and released in the presence
of nocodazole. In (A), at the indicated time intervals, cell-cycle profiles were determined by FACS. The approximate distributions of cell-cycle
phases (S, G2/M) are shown as percentage. AS, asynchronous cell population. In (B), at the indicated time intervals, cells were pulse labeled
for 20 min with 33 mM BrdU, fixed, and stained for BrdU. Results are the mean of two independent experiments. At least 1000 cells were counted
for each time point. Shown are the mean 6 SD values. *p < 0.05; **p < 0.001.
(C–F) Induction of DNA damage in USP3-silenced cells. U2OS cells were transfected twice with control (Ctrl) or USP3 siRNA oligonucleotides
(KD1 and KD2) and analyzed at 72 hr after transfection. Transfected cells were stained for g-H2AX or 53BP1 (C), and quantification for
g-H2AX positivity (D) or presence of 53BP1 foci (E) was performed. At least 300 (for g-H2AX) or 150 (for 53BP1) cells were counted. Cells
containing more than three nuclear foci were considered positive for 53BP1. Scale bars represent 10 mm.
(F) DNA breaks in USP3-depleted U2OS cells were assayed by comet assay. At least 200 cells/sample were analyzed. In (D)–(F), the results are
the mean of three independent experiments. Shown are the mean 6 SD values. *p < 0.05; **p < 0.001.
(G) USP3-depleted cells contain RPA34-coated ssDNA. U2OS cells were prelabeled with 10 mM BrdU, incubated with USP3 (USP3KD2) or control
(Ctrl) siRNA for 48 hr, and immunostained for BrdU without denaturation of the DNA. Scale bar represents 10 mm.
(H) DNA damage checkpoint activation in USP3-depleted cells. IB analysis of Ctrl or USP3KD U2OS cell lysates prepared at 48 hr after transfec-
tion. Chk1 pS315 and Chk2 pT68 indicate antibodies specific for the phosphorylated amino acid of the protein.replication might cause this delay (see below). We con-
clude that USP3 is required for proper progression
through S phase and subsequent mitotic entry.
Induction of DNADamage andCheckpoint Activation
in USP3-Silenced Cells
One cause of S phase delay and mitotic arrest is DNA
damage together with DNA damage checkpoint activa-
tion. Chromatin folding and histone modifications play
an important role in DNA damage response (DDR) [11].
Therefore, we tested whether USP3-KD could affect ge-
nome integrity in nonchallenging conditions. An early re-
sponse to DNA damage is the phosphorylation of H2AX
(g-H2AX) at DNA breaks by the ataxia telangiectasia mu-
tated (ATM) and ATM- and Rad3-related (ATR) check-
point kinases [12]. As shown in Figures 3C–3E, g-H2AX
staining, as well as accumulation of the checkpoint pro-
tein 53BP1 [13] in nuclear foci, was enriched in USP3-KD
U2OS cells. Complementation experiments showed that
USP3 catalytic activity was required to rescue USP3-KD
cells from accumulating g-H2AX (Figure S7).
To investigate whether DNA damage was present in
USP3-KD cells, we performed a comet assay under al-
kaline conditions [14]. DNA breaks were readily de-
tected in USP3-KD cells (Figure 3F). Positive detectionof comet tails was not due to a general apoptotic pro-
gram, because apoptotic-typical nuclear morphology
was not evident (Figure 3C) and caspase activity was
not significantly induced (not shown).
DNA damage or stalled replication activates the ATR-
Chk1 pathway in a manner dependent on the associa-
tion of the replication protein A (RPA) to single-stranded
DNA (ssDNA; [15]). To assess the presence of ssDNA,
we measured BrdU incorporation without prior dena-
turation of the DNA [16]. Only USP3-depleted cells
showed numerous BrdU foci colocalizing with the
ssDNA binding protein RPA34, indicating the formation
of ssDNA (Figure 3G). Consistent with the presence of
DNA breaks, there were significantly higher levels of
g-H2AX and of activated ATM and ATR targets, Chk2
(phosphorylated at Thr68) and Chk1 (phosphorylated
at Ser345) in USP3-KD cells than in control cells (Fig-
ure 3H) [12]. Of note, Ser345 is the preferential site for
phosphorylation by ATR in response to stalled replica-
tion forks [17], suggesting that the ATR/Chk1 pathway
is also activated and that USP3-KD cells undergo repli-
cative stress.
Altogether, these data suggest that USP3 inhibition
leads to accumulation of DNA breaks and activation of
an ATM/ATR-regulated DNA damage response pathway.
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1976Figure 4. Ionizing Radiation Induces uH2A Nuclear Foci Formation, and Depletion of USP3 Increases the Persistence of uH2A and g-H2AX Foci in
Response to DSB
(A) U2OS cells were exposed to IR, stained for uH2A and g-H2AX or uH2A and pS/TQ Ab at 30 min after IR, and analyzed by confocal microscope.
Scale bars represent 5 mm.
(B) Left: Ctrl or USP3KD U2OS cells were treated with IR (1Gy) at 48 hr after transfection and stained for g-H2AX (top) or uH2A (bottom) as indi-
cated. Ab staining was merged with DAPI and images were processed to show only the periphery of the nucleus (thin white lines). Scale bars
represent 10 mm. Right: g-H2AX foci-positive cells were quantified as described in Figure 3. Cells containing more than five foci were considered
positive for uH2A. The results are the mean of two independent experiments. Shown are the mean 6 SD values. *p < 0.05; **p < 0.001.Evidence for an Involvement of USP3
in the Response to DNA Damage
The above results led us to hypothesize that USP3, pos-
sibly through its ability to deubiquitinate H2A/H2B,
might affect the response to and/or the repair of exoge-
nous DNA damage. Previous observations suggest that
histones are ubiquitinated upon UV damage [18, 19].
Ubiquitination of H2B in S. cerevisiae is required for
checkpoint activation upon genotoxic stress [20]. In ad-
dition, nuclear foci of conjugated ubiquitin are detected
at IR-induced damage sites with an antibody recogniz-
ing conjugated Ub (FK2) (Figures S10 and S11; [21,
22]). We analyzed uH2A upon IR. uH2A redistribution to
nuclear foci and significant colocalization with g-H2AX
foci and with phosphorylated ATM/ATR substrates
(pS/TQ Ab) was observed early upon IR (Figure 4A; Fig-
ures S8 and S9). Accumulation of Ub conjugates was
present in a patient cell line with reduced ATR expres-
sion, but was less evident in cells deficient for ATM,
which is primarily involved in DSB-induced signaling
(Figure S10).
g-H2AX is phosphorylated within minutes upon IR, and
its dephosphorylation is required for full recovery from
the DDR[23, 24]. We thereforeexamined the kinetic of for-
mation/disappearance of g-H2AX and uH2A/Ub (FK2)
foci upon IR in USP3-silenced cells. At 30 min after IR,
there was comparable foci formation in control and
USP3-KD cells. However, g-H2AX and uH2A/Ub foci
persisted for a prolonged time, with more than 50% of
the silenced cells displaying foci up to 40 hr post IR
(Figure 4B; Figure S11). In line with g-H2AX kinetics,
USP3-KD cells entered a IR-induced G2 arrest similarly
to control cells but showed a prolonged G2/M checkpoint
(Figure S12). These data suggest that USP3 plays a role in
deubiquitination events, including H2A deubiquitination,
at DNA damage sites, and might thereby contribute to
an efficient recovery from the DNA damage checkpoint.
Whether loss of USP3 leads to a checkpoint defect or
rather a DNA repair defect remains to be established.Conclusions
Our results identify USP3 as a novel regulator of uH2A
and uH2B and suggest that USP3 might have an impor-
tant role in genome-wide H2A deubiquitination. In addi-
tion, USP3 KD was genotoxic, leading to DNA damage
checkpoint activation. Thus, while we cannot exclude
that the effect on the DNA damage checkpoint is due
to other putative targets of USP3, our results suggest
that USP3 affects the DDR through deubiquitination of
its major substrate, uH2A.
How can H2A ubiquitination influence the DNA dam-
age response? A first possibility is that the ubiquitin
moiety on H2A could promote recruitment and/or stabi-
lization of regulatory factors, containing ubiquitin-bind-
ing domains [1], that in turn play a role in the DNA dam-
age response/DNA repair. Of note, the ubiquitin-binding
protein RAP80 has been shown to bind to ubiquitin con-
jugates at DSB, thereby promoting BRCA1 recruitment
[25, 26]. Second, uH2A could influence post-transla-
tional modification of other histones. Such a cross-talk
between H2B ubiquitination and H3 methylation has
been documented [27].
In USP3-silenced cells, we observe accumulation of
DNA damage, S phase delay, and activation of an ATR/
ATM-regulated checkpoint response. How do these
events relate to each other? One plausible explanation
is that USP3 might, directly or indirectly, affect the DDR.
Under this scenario, ubiquitin conjugates would most
likely function as a signal for the presence of DNA dam-
age. Supporting this hypothesis, a number of ubiquitina-
tion events have been described at DSBs, including
monoubiquitination of repair proteins and accumulation
of ubiquitin polymers [2, 26]. Our results suggest that
uH2A may bepart of this ubiquitin-signaling network. The
role of USP3 might involve removal of ubiquitin marks
from chromatin(-bound proteins) to attenuate the signal.
Absence of USP3 might, thus, lead to hyperactivation
of the checkpoint that, in turn, could result in replica-
tion and/or recombination abnormalities and genotoxic
Histone Deubiquitination by USP3
1977events. Alternatively, the primary function of USP3 might
be related to DNA replication. Replicative stress in the
absence of USP3 may lead to stalled or damaged repli-
cation forks that would generate single-stranded DNA
regions and DNA breaks, and, therefore, checkpoint
signals.
uH2A and uH2B have been associated with transcrip-
tional regulation [27]. Thus, the possibility that USP3 is
involved also in transcription deserves experimental
attention.
In summary, our studies implicate USP3 in DNA dam-
age signaling and reveal a crucial function of USP3 in
preventing replication stress.
Supplemental Data
Twelve figures and Experimental Procedures are available at http://
www.current-biology.com/cgi/content/full/17/22/1972/DC1/.
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